Medicus Sciences Acquisition Corp. (NasdaqCM:MSAC) (MSAC) signed a non-binding letter of intent to acquire Anteris Technologies Ltd (ASX:AVR) on February 8, 2022. All existing Anteris shareholders will receive shares in MSAC in exchange for their shares.

The proposal contemplates an issuance of new equity by MSAC in exchange for the current shares in Anteris at an equivalent value and stipulates that post-transaction the merged entity.